Recursion Pharmaceuticals Inc (RXRX)
5.695
-0.06
(-0.96%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.06
(+0.97%)
After-Hours: 19:37
Recursion Pharmaceuticals Profit Margin (Quarterly): -367.5% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -367.5% |
| June 30, 2024 | -677.2% |
| March 31, 2024 | -677.3% |
| December 31, 2023 | -875.3% |
| September 30, 2023 | -920.8% |
| June 30, 2023 | -696.5% |
| March 31, 2023 | -538.4% |
| December 31, 2022 | -420.4% |
| September 30, 2022 | -463.1% |
| Date | Value |
|---|---|
| June 30, 2022 | -856.7% |
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -2.60K% |
| September 30, 2021 | -1.90K% |
| June 30, 2021 | -1.74K% |
| March 31, 2021 | -1.23K% |
| December 31, 2020 | -1.01K% |
| September 30, 2020 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.77K%
Minimum
Sep 2020
-367.5%
Maximum
Sep 2024
-1.11K%
Average
-875.3%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Revance Therapeutics Inc | -63.65% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.32% |
| Return on Assets | -56.47% |
| Return on Invested Capital | -76.30% |
| Gross Profit Margin (Quarterly) | 53.69% |
| Operating Margin (Quarterly) | -377.1% |
| Return on Net Operating Assets | -166.5% |